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ImmunohistochemistryWe, here, report a case of primary breast lymphoma in a 59 years old female. The diagnosis was suspected onﬁne
needle aspiration cytology and conﬁrmed on excision biopsy of the tumor. Histology and immunophenotyping
were in accordance with non-Hodgkin's diffuse large B-cell lymphoma. The patient has been planned for adju-
vant chemoradiation. Themanagement and outcome of primary breast lymphoma and carcinoma are totally dif-
ferent. Early and prompt diagnosis of primary breast lymphoma is of utmost importance to avoid unnecessary
mastectomies. Fine needle aspiration cytology supplemented by immuno-cytochemistry can be applied as a re-
liable and cost-effective tool in the early diagnosis of primary breast lymphomas, while histopathology and im-
munohistochemistry are conclusive.i 65, India.
upta),
il.com (S. Sing
ail.com (R. Se
en access arti
mary non-H
6.07.004© 2016 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Malignant lymphoma is a neoplasmwhich originates in lymphatic tis-
sue. Primarynon-Hodgkin's lymphomaof the breast is very rare and adis-
tinct possibility in the diagnosis of breast malignancies, accounting for
only about 0.1 to 0.5% of all reported malignant breast tumors and for
1.7–2.2% of extra nodal NHL [1]. There are various kinds of breast lympho-
mas, but themost common is the B cell non-Hodgkin's lymphoma. At pre-
sentation, most patients are clinically thought to have breast carcinoma
and the diagnosis of lymphoma is made at FNAC or at histopathology of
the excised breast lump as in our case. In terms of clinical prognosis, an
early diagnosis of a low grade or stage I lymphoma will generally give
the best outcome. The management is by surgery, chemotherapy and ra-
diotherapy alone or usually in various combinations depending on the
histological subtype, disease extent and individual patient. In view of
the rarity of the lesion, the case is being reportedwith reviewof literature.2. Case report
A59 years old female from rural area presented to our outpatient de-
partment with a lump in left breast for previous 7 months with no con-
stitutional symptoms. There was no complaint of pain or nipple
discharge. On local examination, a ﬁrm to hard lump of about 1.4
× 1.0 cm in upper outer quadrant of left breast andﬁxed to the overlying
skinwas found. Therewas no history of trauma. Rest of the systemic ex-
amination was within normal limits.h),
n).
cle under the CC BY-NC
odgkin's lymphoUSG showed a cystic lesion measuring 1.3 × 1.2 cmwith wall calciﬁca-
tion at 2 o'clock position in left breast. Onmammography, therewas a small
oval radio-opaque lesionwith irregularmargins in upper outer quadrant of
left breastwithmaintenance of retroareolar space (Fig. 1). Fine needle aspi-
ration cytology (FNAC) smears prepared from the lump showed it to be a
lymphoproliferative disorder with few groups of duct epithelial cells with
degenerative changes in background of lymphoid cells, many of which
were immature/atypical including few cleared forms, lymphoglandular
bodies and RBCs (Fig. 2). On Excision biopsy of the lump, there was dense
inﬁltration by sheets of lymphoid cells; on immunohistochemistry (IHC),
cells were diffusely positive for LCA and CD20, focally positive for CD5
and negative for CK, synaptophysin, ER, PR and Her 2 neu receptors. Inves-
tigations showed Hb 10.4 g/dl, with normal total and differential leukocyte
counts andplatelet count. ESR40mmin1st hour. Liver andkidney function
tests were within normal limits. Chest X-ray and USG abdomen were nor-
mal. So, a provisional diagnosis of lymphoproliferative disorder was made.
Histopathological examination of the tumor conﬁrmed the diagnosis to be
the primary breast non-Hodgkin's diffuse large B-cell lymphoma (DLBC
NHL). On immunohistocytochemistry (IHC)
CD 20: Diffusely positive
CD 5: Focally positive
CK: Positive in ducts (Figs. 3 and 4).
The patient is on regular follow-up, doingwell and has been planned
for adjuvant chemoradiation.
3. Discussion
Primary breast lymphoma (PBL) is deﬁned pathologically as the
presence of lymphomatous inﬁltrate in normal breast tissue in a patient
with neither previous nor concurrent non-Hodgkin's lymphoma at-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
ma of breast – A rare cause of breast lump, Human Path Case Reports
Fig. 1.Mammogram showing a small oval radio-opaque lesion with irregular margins in
upper outer quadrant of left breast with maintenance of retroareolar space.
Fig. 2. FNAC breast lump showing few groups of duct epithelial cells with degenerative
changes in background of lymphoid cells, many of whichwere immature/atypical includ-
ing few cleared forms, lymphoglandular bodies and RBCs (400×).
2 V. Gupta et al. / Human Pathology: Case Reports xxx (2016) xxx–xxxanother site, although involvement of ipsilateral axillary lymph node
enlargement may be present [2]. It is a rare tumor and often present
as an innocuous lump. PBL shows awide age distributionwith a bimod-
al peak; with younger population showing bilateral involvement and
older population showing unilateral involvement [3]. The majority of
breast lymphomas are of the non-Hodgkin's lymphoma type (PBNHL).
It usually affects women in their ﬁfth or sixth decade of life. The most
common symptom of PBL is a palpable lump; less frequently, it may
present as diffuse breast enlargement. There is usually unilateral in-
volvement, but bilateral cases have also been reported [2]. Wiseman
and Liao are credited with ﬁrst deﬁning the clinical criteria for the clas-
siﬁcation of PBL [4]. The speciﬁc criteria for the diagnosis of PBL include:
1. The clinical site of presentation is the breast.
2. A history of previous lymphoma or evidence of widespread disease
are absent at diagnosis.
3. Lymphoma is demonstratedwith close association to breast tissue in
the pathologic specimen.
4. Ipsilateral lymph nodes may be involved if they develop simulta-
neously with the primary breast tumor.
On ultrasound, PBNHL often presents as a hypoechoic area with
circumscribed ormicrolobulatedmargins demonstrating increased vas-
cularity [5]. The typical mammographic appearance of PBNHL consists
of a solitary, noncalciﬁed, circumscribed or indistinctly marginated
mass with adjacent lymphadenopathy. Less commonly, diffuse in-
creased parenchymal density with skin thickening is observed [2]. MRI
may be more sensitive and accurate in representing and detecting
multicentric lesions.Please cite this article as: V. Gupta, et al., Primary non-Hodgkin's lympho
(2016), http://dx.doi.org/10.1016/j.ehpc.2016.07.004The clinical presentation and radiology of breast lymphoma and car-
cinoma are similar. Both present as painless enlarging breast lump. On
mammogram lymphoma may lack the irregular border of inﬁltrating
carcinoma and more than half exhibit no calciﬁcation. Pathology re-
mains the gold standard to differentiate these two malignancies. Histo-
pathology, IHC and/or ﬂow cytometry are helpful in differentiating
primary breast lymphoma from other tumors [6].
All histological types of lymphoma have been described. Primary
breast lymphomas are most commonly B-cell lymphomas; approxi-
mately one-half are diffuse large B-cell lymphoma (DLBCL). Indolent
histologies, follicular non-Hodgkin's lymphoma or extranodal marginal
zone (MALT) lymphomaoccur less commonly.More than 80% of PBL are
B-cell lymphomas, mostly CD20+. The most frequent histopathologic
types are: diffuse large B-cell lymphoma (DLBCL) which accounts for
up to 50% of all PBL, follicular lymphoma (FL) – 15%, MALT lymphoma
– 12.2%, Burkitt's lymphoma (BL) and Burkitt-like lymphoma 10.3%.
Other histological types of PBL include marginal zone lymphoma
(MZL), small lymphocytic lymphoma (SLL), and anaplastic large cell
lymphoma (ALCL). These lymphomas have been shown to be of a
non-germinal centre B-cell phenotype with a high proliferation index
and are thought to be associated with a poor outcome. Although less
common than breast carcinoma, PBL is often clinically indistinguishable
from other breast tumors. Although primary breast lymphoma and car-
cinoma may appear similar clinically and radiographically, their treat-
ments and outcome differ radically. Also because of the rapid growth
of lymphoma, it is very important to distinguishprimary breast lympho-
ma from carcinoma in early stages [7].
The management of Primary Non-Hodgkin's lymphoma of breast is
based on histologic grade. Patients with low grade disease can be man-
agedwith local therapy alone. The role of chemotherapy in this group is
unclear. Patients with intermediate or high grade disease have better
out come if chemotherapy is included.
Disagreement regarding the treatment of such disease stems
from its rareness, with small case reports; consequently, randomized
controlled trials or clinically controlled trials cannot be carried
out. The prognosis varies, as do the applied treatment modalities,
which include surgery, radiotherapy and chemotherapy used alone or
in combination.
Mastectomy has been a common component of PBL therapy for de-
cades and remains a frequent treatment choice in some reports. Several
studies found that mastectomy offered no beneﬁt in the treatment of
primary breast lymphoma [5,7,8]. Ideally, surgery should be limited to
a biopsy to establish the correct histological diagnosis, leaving the treat-
ment with curative intent to radiotherapy and chemotherapy.ma of breast – A rare cause of breast lump, Human Path Case Reports
Fig. 3. Photomicrograph showing dense inﬁltration by lymphoid cells of breast tissue sug-
gesting the diagnosis of diffuse large cell lymphoma in breast (A - 40×, B - 100× and C -
400×) on H & E.
Fig. 4. Immunohistochemistry (IHC) staining. CD5: focally positive, CD20: diffusely posi-
tive and CK: positive in ducts (200×).
3V. Gupta et al. / Human Pathology: Case Reports xxx (2016) xxx–xxxJennings et al. reviewed all published PBL reports from 3 decades
(1972–2005) and concluded that mastectomy offers no beneﬁt to the
treatment of PBL. Nodal status predicts outcome and guides the optimal
use of radiation and chemotherapy [9].
Treatment of primary breast lymphomas follows treatment recom-
mendations for lymphomas of the same stage and histology in otherPlease cite this article as: V. Gupta, et al., Primary non-Hodgkin's lymphoma of breast – A rare cause of breast lump, Human Path Case Reports
(2016), http://dx.doi.org/10.1016/j.ehpc.2016.07.004
4 V. Gupta et al. / Human Pathology: Case Reports xxx (2016) xxx–xxxlocations. The choice of chemotherapeutic regimen should be based
upon histological subtype, disease extent and the individual patient.
The role of central nervous system (CNS) prophylaxis inDLBCL of the
breast is controversial. Nevertheless, given this high incidence of CNS
recurrence, central nervous system (CNS) prophylaxis should be con-
sidered [10–12].
4. Conclusion
Primary malignant lymphoma of the breast (PLB) is a rare but very
important differential diagnosis of a breast lump. A high degree of clin-
ical suspicion is required for an early and prompt diagnosis of primary
breast lymphoma so as to avoid unnecessary mastectomies. Fine needle
aspiration cytology supplemented by immuno-cytochemistry is a reli-
able and cost-effective tool in the early diagnosis of primary breast lym-
phomas, while histopathology and immunohistochemistry are
conclusive. While examining cytology of painless breast lump, the dif-
ferential diagnosis of primary breast lymphoma should always be con-
sidered. The diagnosis of primary breast lymphoma must always be
conﬁrmed by histopathology and immunohistochemistry. Themanage-
ment depends on the histological subtype, disease extent and individual
patient and chemotherapy seems to be the most acceptable option,
alone or in combination with surgery and radiotherapy.Please cite this article as: V. Gupta, et al., Primary non-Hodgkin's lympho
(2016), http://dx.doi.org/10.1016/j.ehpc.2016.07.004References
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